Global Biosimilar Testing and Development Services Market Research Report 2023

Report ID: 1983071 | Published Date: Jan 2025 | No. of Page: 87 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Biosimilar Testing and Development Services Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Effector Binding
        1.2.3 ELISA
        1.2.4 Kinetic Binding Assays
        1.2.5 ADCC & CDC Cell-Based Assays
    1.3 Market by Application
        1.3.1 Global Biosimilar Testing and Development Services Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 PK assay
        1.3.3 Tiered Immunogenicity testing
        1.3.4 NAb assays
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Biosimilar Testing and Development Services Market Perspective (2017-2028)
    2.2 Biosimilar Testing and Development Services Growth Trends by Region
        2.2.1 Biosimilar Testing and Development Services Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Biosimilar Testing and Development Services Historic Market Size by Region (2017-2022)
        2.2.3 Biosimilar Testing and Development Services Forecasted Market Size by Region (2023-2028)
    2.3 Biosimilar Testing and Development Services Market Dynamics
        2.3.1 Biosimilar Testing and Development Services Industry Trends
        2.3.2 Biosimilar Testing and Development Services Market Drivers
        2.3.3 Biosimilar Testing and Development Services Market Challenges
        2.3.4 Biosimilar Testing and Development Services Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Biosimilar Testing and Development Services Players by Revenue
        3.1.1 Global Top Biosimilar Testing and Development Services Players by Revenue (2017-2022)
        3.1.2 Global Biosimilar Testing and Development Services Revenue Market Share by Players (2017-2022)
    3.2 Global Biosimilar Testing and Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Biosimilar Testing and Development Services Revenue
    3.4 Global Biosimilar Testing and Development Services Market Concentration Ratio
        3.4.1 Global Biosimilar Testing and Development Services Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Testing and Development Services Revenue in 2021
    3.5 Biosimilar Testing and Development Services Key Players Head office and Area Served
    3.6 Key Players Biosimilar Testing and Development Services Product Solution and Service
    3.7 Date of Enter into Biosimilar Testing and Development Services Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilar Testing and Development Services Breakdown Data by Type
    4.1 Global Biosimilar Testing and Development Services Historic Market Size by Type (2017-2022)
    4.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Type (2023-2028)
5 Biosimilar Testing and Development Services Breakdown Data by Application
    5.1 Global Biosimilar Testing and Development Services Historic Market Size by Application (2017-2022)
    5.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Biosimilar Testing and Development Services Market Size (2017-2028)
    6.2 North America Biosimilar Testing and Development Services Market Size by Country (2017-2022)
    6.3 North America Biosimilar Testing and Development Services Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Biosimilar Testing and Development Services Market Size (2017-2028)
    7.2 Europe Biosimilar Testing and Development Services Market Size by Country (2017-2022)
    7.3 Europe Biosimilar Testing and Development Services Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Biosimilar Testing and Development Services Market Size (2017-2028)
    8.2 Asia-Pacific Biosimilar Testing and Development Services Market Size by Country (2017-2022)
    8.3 Asia-Pacific Biosimilar Testing and Development Services Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Biosimilar Testing and Development Services Market Size (2017-2028)
    9.2 Latin America Biosimilar Testing and Development Services Market Size by Country (2017-2022)
    9.3 Latin America Biosimilar Testing and Development Services Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Biosimilar Testing and Development Services Market Size (2017-2028)
    10.2 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2017-2022)
    10.3 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Eurofins Scientific
        11.1.1 Eurofins Scientific Company Detail
        11.1.2 Eurofins Scientific Business Overview
        11.1.3 Eurofins Scientific Biosimilar Testing and Development Services Introduction
        11.1.4 Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2017-2022)
        11.1.5 Eurofins Scientific Recent Development
    11.2 SGS
        11.2.1 SGS Company Detail
        11.2.2 SGS Business Overview
        11.2.3 SGS Biosimilar Testing and Development Services Introduction
        11.2.4 SGS Revenue in Biosimilar Testing and Development Services Business (2017-2022)
        11.2.5 SGS Recent Development
    11.3 Charles River Laboratories
        11.3.1 Charles River Laboratories Company Detail
        11.3.2 Charles River Laboratories Business Overview
        11.3.3 Charles River Laboratories Biosimilar Testing and Development Services Introduction
        11.3.4 Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2017-2022)
        11.3.5 Charles River Laboratories Recent Development
    11.4 Pharmaceutical Product Development
        11.4.1 Pharmaceutical Product Development Company Detail
        11.4.2 Pharmaceutical Product Development Business Overview
        11.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Introduction
        11.4.4 Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2017-2022)
        11.4.5 Pharmaceutical Product Development Recent Development
    11.5 Exova
        11.5.1 Exova Company Detail
        11.5.2 Exova Business Overview
        11.5.3 Exova Biosimilar Testing and Development Services Introduction
        11.5.4 Exova Revenue in Biosimilar Testing and Development Services Business (2017-2022)
        11.5.5 Exova Recent Development
    11.6 Source BioScience
        11.6.1 Source BioScience Company Detail
        11.6.2 Source BioScience Business Overview
        11.6.3 Source BioScience Biosimilar Testing and Development Services Introduction
        11.6.4 Source BioScience Revenue in Biosimilar Testing and Development Services Business (2017-2022)
        11.6.5 Source BioScience Recent Development
    11.7 Intertek Group
        11.7.1 Intertek Group Company Detail
        11.7.2 Intertek Group Business Overview
        11.7.3 Intertek Group Biosimilar Testing and Development Services Introduction
        11.7.4 Intertek Group Revenue in Biosimilar Testing and Development Services Business (2017-2022)
        11.7.5 Intertek Group Recent Development
    11.8 Medistri
        11.8.1 Medistri Company Detail
        11.8.2 Medistri Business Overview
        11.8.3 Medistri Biosimilar Testing and Development Services Introduction
        11.8.4 Medistri Revenue in Biosimilar Testing and Development Services Business (2017-2022)
        11.8.5 Medistri Recent Development
    11.9 Pace Analytical Services
        11.9.1 Pace Analytical Services Company Detail
        11.9.2 Pace Analytical Services Business Overview
        11.9.3 Pace Analytical Services Biosimilar Testing and Development Services Introduction
        11.9.4 Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2017-2022)
        11.9.5 Pace Analytical Services Recent Development
    11.10 Sigma-Aldrich
        11.10.1 Sigma-Aldrich Company Detail
        11.10.2 Sigma-Aldrich Business Overview
        11.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Introduction
        11.10.4 Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2017-2022)
        11.10.5 Sigma-Aldrich Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Biosimilar Testing and Development Services Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Effector Binding
    Table 3. Key Players of ELISA
    Table 4. Key Players of Kinetic Binding Assays
    Table 5. Key Players of ADCC & CDC Cell-Based Assays
    Table 6. Global Biosimilar Testing and Development Services Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Biosimilar Testing and Development Services Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Biosimilar Testing and Development Services Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Biosimilar Testing and Development Services Market Share by Region (2017-2022)
    Table 10. Global Biosimilar Testing and Development Services Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Biosimilar Testing and Development Services Market Share by Region (2023-2028)
    Table 12. Biosimilar Testing and Development Services Market Trends
    Table 13. Biosimilar Testing and Development Services Market Drivers
    Table 14. Biosimilar Testing and Development Services Market Challenges
    Table 15. Biosimilar Testing and Development Services Market Restraints
    Table 16. Global Biosimilar Testing and Development Services Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Biosimilar Testing and Development Services Market Share by Players (2017-2022)
    Table 18. Global Top Biosimilar Testing and Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Testing and Development Services as of 2021)
    Table 19. Ranking of Global Top Biosimilar Testing and Development Services Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Biosimilar Testing and Development Services Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Biosimilar Testing and Development Services Product Solution and Service
    Table 23. Date of Enter into Biosimilar Testing and Development Services Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Biosimilar Testing and Development Services Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2017-2022)
    Table 27. Global Biosimilar Testing and Development Services Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2023-2028)
    Table 29. Global Biosimilar Testing and Development Services Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Biosimilar Testing and Development Services Revenue Market Share by Application (2017-2022)
    Table 31. Global Biosimilar Testing and Development Services Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Biosimilar Testing and Development Services Revenue Market Share by Application (2023-2028)
    Table 33. North America Biosimilar Testing and Development Services Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Biosimilar Testing and Development Services Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Biosimilar Testing and Development Services Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Biosimilar Testing and Development Services Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Biosimilar Testing and Development Services Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Biosimilar Testing and Development Services Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Eurofins Scientific Company Detail
    Table 44. Eurofins Scientific Business Overview
    Table 45. Eurofins Scientific Biosimilar Testing and Development Services Product
    Table 46. Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
    Table 47. Eurofins Scientific Recent Development
    Table 48. SGS Company Detail
    Table 49. SGS Business Overview
    Table 50. SGS Biosimilar Testing and Development Services Product
    Table 51. SGS Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
    Table 52. SGS Recent Development
    Table 53. Charles River Laboratories Company Detail
    Table 54. Charles River Laboratories Business Overview
    Table 55. Charles River Laboratories Biosimilar Testing and Development Services Product
    Table 56. Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
    Table 57. Charles River Laboratories Recent Development
    Table 58. Pharmaceutical Product Development Company Detail
    Table 59. Pharmaceutical Product Development Business Overview
    Table 60. Pharmaceutical Product Development Biosimilar Testing and Development Services Product
    Table 61. Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
    Table 62. Pharmaceutical Product Development Recent Development
    Table 63. Exova Company Detail
    Table 64. Exova Business Overview
    Table 65. Exova Biosimilar Testing and Development Services Product
    Table 66. Exova Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
    Table 67. Exova Recent Development
    Table 68. Source BioScience Company Detail
    Table 69. Source BioScience Business Overview
    Table 70. Source BioScience Biosimilar Testing and Development Services Product
    Table 71. Source BioScience Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
    Table 72. Source BioScience Recent Development
    Table 73. Intertek Group Company Detail
    Table 74. Intertek Group Business Overview
    Table 75. Intertek Group Biosimilar Testing and Development Services Product
    Table 76. Intertek Group Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
    Table 77. Intertek Group Recent Development
    Table 78. Medistri Company Detail
    Table 79. Medistri Business Overview
    Table 80. Medistri Biosimilar Testing and Development Services Product
    Table 81. Medistri Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
    Table 82. Medistri Recent Development
    Table 83. Pace Analytical Services Company Detail
    Table 84. Pace Analytical Services Business Overview
    Table 85. Pace Analytical Services Biosimilar Testing and Development Services Product
    Table 86. Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
    Table 87. Pace Analytical Services Recent Development
    Table 88. Sigma-Aldrich Company Detail
    Table 89. Sigma-Aldrich Business Overview
    Table 90. Sigma-Aldrich Biosimilar Testing and Development Services Product
    Table 91. Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
    Table 92. Sigma-Aldrich Recent Development
    Table 93. Research Programs/Design for This Report
    Table 94. Key Data Information from Secondary Sources
    Table 95. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Biosimilar Testing and Development Services Market Share by Type: 2021 VS 2028
    Figure 2. Effector Binding Features
    Figure 3. ELISA Features
    Figure 4. Kinetic Binding Assays Features
    Figure 5. ADCC & CDC Cell-Based Assays Features
    Figure 6. Global Biosimilar Testing and Development Services Market Share by Application in 2021 & 2028
    Figure 7. PK assay Case Studies
    Figure 8. Tiered Immunogenicity testing Case Studies
    Figure 9. NAb assays Case Studies
    Figure 10. Biosimilar Testing and Development Services Report Years Considered
    Figure 11. Global Biosimilar Testing and Development Services Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Biosimilar Testing and Development Services Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Biosimilar Testing and Development Services Market Share by Region: 2021 VS 2028
    Figure 14. Global Biosimilar Testing and Development Services Market Share by Players in 2021
    Figure 15. Global Top Biosimilar Testing and Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Testing and Development Services as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Biosimilar Testing and Development Services Revenue in 2021
    Figure 17. North America Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Biosimilar Testing and Development Services Market Share by Country (2017-2028)
    Figure 19. United States Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Biosimilar Testing and Development Services Market Share by Country (2017-2028)
    Figure 23. Germany Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Biosimilar Testing and Development Services Market Share by Region (2017-2028)
    Figure 31. China Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Biosimilar Testing and Development Services Market Share by Country (2017-2028)
    Figure 39. Mexico Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Biosimilar Testing and Development Services Market Share by Country (2017-2028)
    Figure 43. Turkey Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Eurofins Scientific Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
    Figure 46. SGS Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
    Figure 47. Charles River Laboratories Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
    Figure 48. Pharmaceutical Product Development Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
    Figure 49. Exova Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
    Figure 50. Source BioScience Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
    Figure 51. Intertek Group Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
    Figure 52. Medistri Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
    Figure 53. Pace Analytical Services Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
    Figure 54. Sigma-Aldrich Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eurofins Scientific
SGS
Charles River Laboratories
Pharmaceutical Product Development
Exova
Source BioScience
Intertek Group
Medistri
Pace Analytical Services
Sigma-Aldrich
Frequently Asked Questions
Biosimilar Testing and Development Services report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biosimilar Testing and Development Services report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biosimilar Testing and Development Services report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Biowaste Containers

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More